Workflow
多数中小股东反对 飞马国际业绩承诺补偿相关议案未获股东大会通过

Core Viewpoint - The proposal regarding the performance commitment of Feima International was not approved during the 2024 annual general meeting, reflecting shareholder dissatisfaction with the company's performance and commitments [1][2]. Group 1: Shareholder Meeting Outcomes - The proposal on the performance commitment was supported by approximately 48.26 million shares (43.86% of votes) but opposed by about 61.53 million shares (55.91% of votes) [1]. - The controlling shareholder, New Zengding Investment Development Co., Ltd., abstained from voting on this proposal [1]. - The voting results indicate a significant opposition from minority shareholders, with 48.25 million shares in favor (43.85%) and 61.53 million shares against (55.92%) [1]. Group 2: Company Restructuring and Performance Commitments - Feima International underwent restructuring in August 2019, with New Zengding acquiring approximately 287 million shares, representing 29.90% of the post-restructuring total shares [2]. - The restructuring plan included a performance commitment from New Zengding to achieve a net profit of no less than 570 million yuan for the years 2022, 2023, and 2024 [2]. - As of April, the cumulative net profit reported by Feima International for 2022, 2023, and 2024 was approximately 133 million yuan, significantly below the committed amount, triggering a compensation obligation of about 437 million yuan from New Zengding [2]. Group 3: Investor Concerns and Future Actions - During a recent earnings briefing, investors raised concerns regarding the lack of asset injection commitments that were initially promised during the restructuring process [3]. - Legal experts noted that the failure of the performance commitment proposal may reflect minority shareholders' collective dissatisfaction with the unfulfilled asset injection promises [3]. - The company is currently engaging with shareholders who voted against the proposal to understand their concerns and may consider resubmitting the proposal for further review [3].